european medicines agency glp-1 vision loss recommendation november 2025 What is the pipeline for future medications for obesity? ema glp-1 vision loss recommendation

A comprehensive approach to lasting results consistent weight loss without yo-yo dieting and a healthier rhythm in daily life

The prescription is the last step, not the first

Helmstdter J, Keppeler K, Kster L, Mnzel T, Daiber A, Steven S: Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor

Image Credit: While of My Desk / Shutterstock In a recent study published in the journal Scientific Reports , a group of researchers evaluated whether maternal exposure to glucagon-like peptide-1 (GLP-1) receptor agonists during the periconceptional period or pregnancy is associated with congenital malformations or other adverse pregnancy outcomes

For daily formulations, consistent timing is important

Click here to learn more